“I have had the pleasure of working with Beatrice on both sides of the negotiating table and can unequivocally state that  she  is...”
[ VIEW RECOMMENDATION ]
- Brian Nugent
Former Project Management Director of a Top 5 Global CRO
Current Senior Program Leader of a Top 10 Biotech Company

“I first met Beatrice when I was Vice President of the Anemia/Nephrology Therapeutic Area at Amgen Inc. and she was the Early Development Leader for a pre-IND molecule being considered for clinical development. She quickly impressed me with...”
[ VIEW RECOMMENDATION ]
- Brad Maroni, MD
Former Vice President, Amgen Inc.
Current CMO, Stromedix Inc.

“I found that Beatrice is very knowledgeable, hard working, motivated, and concentrates relentlessly on finding ways to accelerate the program through the various decision points...”
[ VIEW RECOMMENDATION ]
- Michael Gresser, PhD
Former Vice President, Amgen Inc.
Michael Gresser, PhD
Former Vice President, Amgen Inc
Current CSO and Chair of Scientific Advisory Board of Oxford Biotherapeutics
Current CSO of Myelin Repair Foundation
Current Board of Director of Trillium Therapeutics Inc

“For each of these process improvements, Beatrice's experience and insight were crucial to the completion of the projects...”
[ VIEW RECOMMENDATION ]
- Jim Lillibridge, MS.
Director of Contract and Outsourcing, Array Biopharma

“Beatrice’s exceptional expertise and knowledge of the sector has been invaluable in allowing my company to formulate and advance its
development...”
[ VIEW RECOMMENDATION ]
- Christian Rohlff, PhD
CEO of Oxford Biotherapeutics

“I have worked with Beatrice Perotti for approximately 1 year. She has been an extremely valuable asset to efficient execution of 2 late stage
programs...”
[ VIEW RECOMMENDATION ]
- David Bird, PhD
Former Biogen Idec Late Phase Clinical Program Lead